Venatorx Pharmaceuticals, Inc.

Venatorx Pharmaceuticals, Inc. is a private pharmaceutical company founded in 2010. Based in the United States, the company is dedicated to discovering and developing novel anti-infectives to address the growing concerns of multi-drug-resistant bacterial infections and hard-to-treat viral infections. With its slogan, "Discovering & developing novel anti-infectives to treat multi-drug resistant bacterial & hard-to-treat viral infections," Venatorx Pharmaceuticals is committed to making a significant impact in the Health Care and Pharmaceutical industries. In its most recent funding round in 02 September 2022, the company secured a noteworthy investment of $24.70M. This funding is a testament to the investor confidence in Venatorx Pharmaceuticals' innovative approach and potential to address critical medical challenges. As the pharmaceutical landscape continues to evolve, Venatorx Pharmaceuticals is well-positioned to drive advancements in anti-infective treatments and make a meaningful difference in patient care.